Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated Kidney Disease (AMKD) on Capitol Hill

ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness of this rapidly progressive form of genetic kidney disease. The roundtable is being held in conjunction with the nation’s first ever AMKD Awareness Day, which AKF is launching on April 30, 2024. AKF is urging legislators to support a resolution—which will be introduced by Congresswoman Stacey Plaskett—to recognize the day nationwide.  

AMKD results from variants (mutations) in the apolipoprotein L1 (APOL1) gene. While everyone has two copies of the APOL1 gene, people with certain African ancestry, including Black Americans, African Americans, Afro-Caribbeans, and/or Latina/Latinos, are at an increased risk of having these genetic variants that bring an increased risk of developing AMKD.

“Although the genetic link to AMKD is still a relatively new discovery in the kidney world, it is estimated that 13% of Black Americans have two variants of the APOL1 gene, and these individuals have a one in 5 chance of developing kidney disease,” said LaVarne A. Burton, President and CEO of AKF. “It is vital that more people know about the existence and implications of AMKD, especially those who are disproportionately impacted by kidney disease and more likely to have the genetic variants. We are grateful to Congresswoman Plaskett for introducing the resolution for AMKD Awareness Day and we hope this roundtable will show other legislators the importance of supporting this resolution and drawing more attention to this underrecognized disease.”

Featured speaker Alonzo Mourning has been active in the effort to spread awareness of the condition since he was diagnosed with the disease. Although Mourning was diagnosed with kidney disease in the early 2000s, during the height of his basketball career, he only later learned that it was AMKD.

“For many years, I have publicly shared my personal kidney disease story to help educate people about APOL1-mediated kidney disease,” said Mourning. “I am honored to play a role in this new effort to help ensure more families and communities learn about AMKD through the first annual AMKD Awareness Day. By sharing our stories and bringing more attention to AMKD, I hope we can inspire more people to become APOL1 aware—taking charge of their health by knowing their family history of kidney disease, having regular physician checkups and talking to their health care provider about whether genetic testing is recommended.”

After his remarks, Mourning will join three AKF Ambassadors as part of the roundtable discussion, which will be moderated by Burton.

Also participating in the roundtable discussion are:

  • Patrick Gee, AKF Board of Trustees and AKF Ambassador 
  • Quenton Turner-Gee, age 29, AKF Ambassador, diagnosed with APOL1-mediated focal segmental glomerulosclerosis (FSGS), a form of AMKD
  • Emani McConnell-Brent, age 20, AKF Ambassador, diagnosed with APOL1-mediated FSGS  
  • Mary-Beth Roberts, genetic counselor at the Cleveland Clinic

Find updates and more information at KidneyFund.org/APOL1aware.  

Support for AMKD Awareness Day activities, including this roundtable discussion, is provided by Vertex Pharmaceuticals Incorporated.

###

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 21 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.